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Background and purpose
Doxorubicin, a very potent and often used anti-cancer
drug, is largely limited due to the dose-related toxic
effects. The present study investigated whether berberine,
a natural product alkaloid, can reduce the renal injury
induced by doxorubicin.
Experimental approach
Mice of either gender were randomly divided into four
groups: the control group, doxorubicin group, berberine
group, and berberine+doxorubicin group. In the tests,
body weight, general condition and mortality of the mice
were observed, and serum blood urea nitrogen (BUN) and
serum albumin (Alb) levels were determined to evaluate
renal function. Furthermore, the renal was excised for
determination of the weight changes, as well as histo-
pathological analysis in the tissues.
Key results
Mortality rate and significant decline in body weight, and
increased blood urea nitrogen (BUN) and serum albumin
(Alb) levels were observed in doxorubicin-treated mice.
These changes were significantly prevented by pretreat-
ment with berberine. Histopathological studies showed
that doxorubicin caused structural injuries, such as glo-
merular, tubular epithelial alterations and interstitial
edema in the renal. These histopathological changes were
largely attenuated by berberine pretreatment.
Conclusions
These findings indicate that berberine could play an
important role in ameliorating the doxorubicin-induced
toxicity.
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